Parkinson's disease and impaired chemosensitivity to hypoxia

Lancet. 2000 Dec 16;356(9247):2100. doi: 10.1016/S0140-6736(05)74310-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Caffeine / therapeutic use
  • Humans
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology*
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Respiration*
  • Theophylline / therapeutic use*

Substances

  • Phosphodiesterase Inhibitors
  • Caffeine
  • Theophylline